Energy metabolism disorders and potential therapeutic drugs in heart failure.
10.1016/j.apsb.2020.10.007
- Author:
Yanan HE
1
;
Wei HUANG
1
;
Chen ZHANG
1
;
Lumeng CHEN
1
;
Runchun XU
1
;
Nan LI
1
;
Fang WANG
2
;
Li HAN
3
;
Ming YANG
2
;
Dingkun ZHANG
1
Author Information
1. State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
2. Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China.
3. The College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Publication Type:Review
- Keywords:
Cardiac dysfunction;
Energy deficit;
Energy metabolism;
Heart failure;
Hormones;
Natural products;
Substrate metabolism;
Synthetic drugs
- From:
Acta Pharmaceutica Sinica B
2021;11(5):1098-1116
- CountryChina
- Language:English
-
Abstract:
Heart failure (HF) is a global public health problem with high morbidity and mortality. A large number of studies have shown that HF is caused by severe energy metabolism disorders, which result in an insufficient heart energy supply. This deficiency causes cardiac pump dysfunction and systemic energy metabolism failure, which determine the development of HF and recovery of heart. Current HF therapy acts by reducing heart rate and cardiac preload and afterload, treating the HF symptomatically or delaying development of the disease. Drugs aimed at cardiac energy metabolism have not yet been developed. In this review, we outline the main characteristics of cardiac energy metabolism in healthy hearts, changes in metabolism during HF, and related pathways and targets of energy metabolism. Finally, we discuss drugs that improve cardiac function
